Evofem Biosciences (EVFM) Total Debt (2014 - 2026)
Evofem Biosciences (EVFM) posted Total Debt of $362,000 for Q2 2026, down 5.5% from $383,000 a year earlier and down 98.9% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Total Debt (2014 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences' Total Debt came in at $147,000, up 8.9% from FY2024.
- Annual Total Debt shows a five-year compound annual growth rate of -69.1% (FY2020 to FY2025).
- In prior years, Evofem Biosciences' Total Debt was $135,000 in FY2024 (-99.1%), $14.73 million in FY2023 (-62.6%) and $39.42 million in FY2022.
- Quarterly Total Debt has run from a low of $135,000 in Q4 2024 to a high of $129.33 million in Q3 2022 over five years.
- On a year-over-year basis, Total Debt increased in three of the last eight quarters, with an average decline of 28.1%.
- The strongest year-over-year quarter for Total Debt in the past five years was Q2 2023, with growth of 284.8%; the weakest was Q1 2022, with a decline of 99.5%.
- According to Business Quant data, Total Debt for the three prior quarters was $33.4 million (Q1 2026), $147,000 (Q4 2025) and $291,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 362,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 362,000.00 |
| Mar 31, 2026 | 33.40 Mn |
| Dec 31, 2025 | 147,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 31.35 Mn |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 54.65 Mn |
| Dec 31, 2023 | 14.73 Mn |
| Sep 30, 2023 | 13.11 Mn |
| Jun 30, 2023 | 15.60 Mn |
| Mar 31, 2023 | 23.81 Mn |
| Dec 31, 2022 | 61.92 Mn |
| Sep 30, 2022 | 151.83 Mn |
| Jun 30, 2022 | 26.55 Mn |
| Mar 31, 2022 | 467,000.00 |
| Sep 30, 2021 | 68.82 Mn |
| Jun 30, 2021 | 44.41 Mn |
API Access
Evofem Biosciences Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();